Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 330794-35-9 | MDL No. : | MFCD06409942 |
Formula : | C18H28BNO4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CUDCEJRRWNIPDL-UHFFFAOYSA-N |
M.W : | 333.23 | Pubchem ID : | 3415442 |
Synonyms : |
|
Num. heavy atoms : | 24 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.61 |
Num. rotatable bonds : | 6 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 96.43 |
TPSA : | 56.79 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | Yes |
Log Kp (skin permeation) : | -5.91 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 3.41 |
Log Po/w (WLOGP) : | 2.86 |
Log Po/w (MLOGP) : | 1.83 |
Log Po/w (SILICOS-IT) : | 2.24 |
Consensus Log Po/w : | 2.07 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.84 |
Solubility : | 0.0478 mg/ml ; 0.000143 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.28 |
Solubility : | 0.0174 mg/ml ; 0.0000522 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -5.32 |
Solubility : | 0.00158 mg/ml ; 0.00000474 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.22 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
97% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; potassium acetate In dimethyl sulfoxide at 85℃; for 12 h; | A solution of 4-bromobenzylamine (40.0g, 217.0 mmol) in THF (150 mL) was treated with di-tert-butyl dicarbonate (46.0g, 217 mmol) and stirred at rt for 1 h. The reaction mixture was concentrated in vacuo to afford a solid which was purified bychromatography (80:20 Hexanes: EtOAc) afforded the Boc protected amine (63.0 g, 95percent) as a white solid. A solution of the aryl bromide (30.0g, 98.0 mmol) in DMSO (100 mL) was treated with bis(pinacolato)diboron (30.0g, 118 mmol), KOAc (30.0g, 306 mmol), and PdCl2(dppf) (0.2 mmol) and warmed to 85 °C for 12 h. The reaction mixture was diluted with EtOAc (250 mL) and washed with water (2 x 150 mL) and brine (100 mL). The organic layer was dried (Na2SO4) and concentrated in vacuo to afford a solid which was purification by chromatography (80:20 hexanes: EtOAc) afforded the desired cmpd (31.0 g, yield 97percent) as a white solid. ESI-MS (M+H)+: 334. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
99% | With triethylamine In dichloromethane at 20℃; for 2 h; | To a solution of 4-aminomethylphenylboronic acid, pinacol ester (CAS 138500-88-6) (1.2 g, 5.14 mmol) and Et3N (1.42 ml, 10.28 mmol) in DCM (50 ml) stirred at room temperature, di-tert-butyldicarbonate (1.68 g, 7.72 mmol) was added. The mixture was stirred at room temperature for 2 hours. The solvent was evaporated in vacuum to yield 15 a residue which was treated with diethylether to yield intermediate compound 39 (1.7 g) as a solid, 99 percent) used in the next reaction step without further purification. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
78% | With potassium acetate In tetrahydrofuran; n-heptane; dichloromethane; ethyl acetate; N,N-dimethyl-formamide | b Tert-butyl N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]carbamate A mixture of 4-bromobenzylamine hydrochloride (10.0 g, 45.0 mmol), di-tert-butyl dicarbonate (11.8 g, 54.0 mmol) and diisopropylethyl amine (8.7 g, 68 mmol) in tetrahydrofuran (100 mL) was heated at reflux for 1 hour. The mixture was cooled and the solvent evaporated under reduced pressure. The material was dissolved in dichloromethane (200 mL) and then washed with water, dried over magnesium sulfate, filtered and the filtrate concentrated under reduced pressure to provide an oil (14.0 g). The oil was dissolved in N,N-dimethylformamide (250 mL) then treated with diboron pinacol ester (11.4 g, 45 mmol), potassium acetate (13.2 g, 135 mmol) and [1.1'-bis(diphenylphosphino)ferrocene]dichloropalladium (II) complex with dichloromethane (1:1) (1.1 g, 1.35 mmol). The mixture was heated at 85° C. for 18 hours then cooled and the solvent removed under reduced pressure. The residue was stirred with dichloromethane (250 mL) then filtered through a pad of celite. The filtrate was concentrated under reduced pressure and the residue purified by flash chromatography on silica gel using heptane/ethyl acetate (8:2) as an eluent to provide tert-butyl N-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]carbamate (11.8 g, 78percent):: 1H NMR (DMSO-d6, 400 MHz) δ7.63 (d, 2H), 7.40 (t, 1H), 7.23 (d, 2H), 4.14 (d, 2H), 1.39 (s, 9H), 1.28 (s, 12H); RP-HPLC (Hypersil HS C18, 5 μm, 100 A, 250*4.6 mm; 25percent-100percent acetonitrile over 10 min, 1 mL/min) tr 12.65 min. |
[ 905273-91-8 ]
tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindoline-2-carboxylate
Similarity: 0.93
[ 1032528-06-5 ]
tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate
Similarity: 0.89
[ 1035235-26-7 ]
tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
Similarity: 0.87
[ 2126812-29-9 ]
Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenethylcarbamate
Similarity: 0.87
[ 956136-85-9 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate
Similarity: 0.86
[ 1032528-06-5 ]
tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate
Similarity: 0.89
[ 2126812-29-9 ]
Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenethylcarbamate
Similarity: 0.87
[ 956136-85-9 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate
Similarity: 0.86
[ 330793-01-6 ]
tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
Similarity: 0.84
[ 489446-42-6 ]
(4-(((tert-Butoxycarbonyl)amino)methyl)phenyl)boronic acid
Similarity: 0.82
[ 905273-91-8 ]
tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindoline-2-carboxylate
Similarity: 0.93
[ 1032528-06-5 ]
tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate
Similarity: 0.89
[ 1035235-26-7 ]
tert-Butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroisoquinoline-2(1H)-carboxylate
Similarity: 0.87
[ 2126812-29-9 ]
Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenethylcarbamate
Similarity: 0.87
[ 956136-85-9 ]
tert-Butyl 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidine-1-carboxylate
Similarity: 0.86
[ 1032528-06-5 ]
tert-Butyl (1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclobutyl)carbamate
Similarity: 0.89
[ 2126812-29-9 ]
Benzyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenethylcarbamate
Similarity: 0.87
[ 330793-01-6 ]
tert-Butyl (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamate
Similarity: 0.84
[ 489446-42-6 ]
(4-(((tert-Butoxycarbonyl)amino)methyl)phenyl)boronic acid
Similarity: 0.82
[ 909391-56-6 ]
N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
Similarity: 0.80